Association of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene with type 2 diabetes in two ethnic groups of Jerba Island in Tunisia
Restricted accessOtherFirst published online March, 2009
Association of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene with type 2 diabetes in two ethnic groups of Jerba Island in Tunisia
Introduction.The aim of the current study was to evaluate the role of angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism on the prediction of type 2 diabetes in two ethnic populations from Jerba Island,Tunisia.
Methods. In this study, we analysed the genotypic and the allelic distributions of the ACE I/D polymorphism and conducted a case/control association study between healthy normoglycaemic controls and diabetic patients in the two studied groups.ACE gene polymorphism was analysed by polymerase chain reaction in 272 individuals consisting of 172 diabetic subjects and 100 controls.
Results.The genotype frequencies for DD, ID and II were 75.50%, 19.60% and 4.89% inArabs and 76.66%, 16.66% and 6.67% in Berbers, respectively, in the case group, and 42.85%, 35.71% and 21.43% inArabs and 57.50%, 22.50% and 20.00% in Berbers, respectively, in the control group.The DD frequency was significantly higher in the case group than in the control group (p<0.001), suggesting that the DD genotype is associated with an increased susceptibility to type 2 diabetes in our study populations.
Conclusions.The current investigation provides new evidence regarding the role of the ACE I/D polymorphism in the pathogenesis of type 2 diabetes in Jerbian populations. Furthermore, it underlines the importance of ethnicity, which should be considered in all studies aiming to test the genetic effects on the susceptibility to type 2 diabetes.
Zimmet P., Alberti KG, Shaw J.Global and societal implications of the diabetes epidemic. Nature2001;414:782-7.
2.
World Health Organization.Diabetes Mellitus: Report of a WHO Study Group. Technical Report Series No 727. Geneva: World Health Organization, 1985.
3.
McCarthy M., Menzel S.The genetics of type 2 diabetes. Br J Clin Pharmacol2001;51:195-9.
4.
Lieberman J. , Sastre A.Serum angiotensin converting enzyme: elevations in diabetes mellitus. Arch Intern Med1980 ;93:825-6.
5.
Feng Y., Niu T., Xu X. et al. Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes2002;51:1986-8.
6.
Wong TY, Chan JC, Poon E., Li PKLack of association of angiotensin converting enzyme (DD/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes. Am J Kidney Dis1999;33:1064-70.
7.
Thomas GN, Tomlinson B., Chan JC, Sanderson JE, Cockram CS, Critchley JARenin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of the ACE insertion/deletion polymorphism with type 2 diabetes. Diabetes Care2001;24:356-61.
8.
Stephens JW, Dhamrait SS, Cooper JA et al. The D allele of the ACE I/D common gene variant is associated with type 2 diabetes mellitus in Caucasian subjects. Mol Genet Metab2005;84:83-9.
9.
Hsieh MC, Lin SR, Hsieh TJ et al. Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant2000;15:1008-3.
10.
Schmidt S., Schone N., Ritz E.Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int1995;47:1176-81.
11.
Mathew J., Basheeruddin K., Prabhakar S.Differences in frequency of the deletion polymorphism of the angiotensin-converting enzyme gene in different ethnic groups. Angiology2001;52:375-9.
12.
Bouguerra R. , Alberti H., Salem LB et al. The global diabetes pandemic: the Tunisian experience. Eur J Clin Nutr2007;61:160-5.
13.
Arfa I., Abid A., Nouira S. et al. Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst2008;9:32-6.
14.
Rebai M., Kharrat N., Ayadi I., Rebai A.Haplotype structure of five SNPs within the ACE gene in the Tunisian population . Ann Hum Biol2006;33:319-29.
15.
Ennafaa H., Ben Amor M., Loueslati B. et al. Alu polymorphisms in Jerba Island population (Tunisia): comparative study in Arab and Berber groups. Ann Hum Biol2006;33:634-40.
16.
Cherni L., Loueslati BY, Pereira L., Ennafaa H., Amorim A., El Gaaied ABFemale gene pools of Berber and Arab neighbouring communities in central Tunisia: microstructure mt DNA variation in North Africa. Hum Biol2005;77:61-70.
17.
Abdennaji GB , Yacoubi LB, Buhler S. et al. HLA class II genetic diversity in Southern Tunisia and the Mediterranean area. Int J Immunogenet2006;33:93-103.
18.
Singh PP, Naz I., Gilmour A., Singh M., Mastana S.Association of APOE (Hha1) and ACE (I/D) gene polymorphisms with type 2 diabetes mellitus in North West India. Diabetes Res Clin Pract2006;74:95-102.
19.
Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F.An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest1990;86:1343-6.
20.
Tiret L., Rigat B., Visvikis S. et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet1992;51:197-205.
21.
Lee YJ, Tsai JCACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients . Diabetes Care2002;25:1002-8.
Bengtsson K. , Orho-Melander M., Lindblad U. et al. Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg hypertension and diabetes project. J Hypertens1999;17:1569-75.
24.
Chuang LM, Chiu KC, Chiang FT et al. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with hypertension, non-insulin-dependent diabetes mellitus, and coronary heart disease in Taiwan. Metabolism1997;46:1211-4.
25.
Ewens WJ, Spielman RSThe transmission/disequilibrium test: history, subdivision, and admixture . Am J Hum Genet1995;57:455-64.
26.
Foy CA, McCormack LJ, Knowler WC, Barrett JH, Catto A., Grant PJThe angiotensin-I converting enzyme (ACE) gene I/D polymorphism and ACE levels in Pima Indians. J Med Genet1996 ;33:336-7.
27.
Vishwanathan V., Zhu Y., Bala K. et al. Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. JOP2001;2:83-7.
28.
Gutierrez C. , Vendrell J., Pastor R. et al. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in Caucasian Mediterranean population. Metabolism1997;46:976-80.
29.
Pasha A., Khan A., Kumar R. et al. Variations in angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian populations of different ethnic origins. J Biosci2002;27:67-70.
30.
Hattori Y., Akimoto K., Gross S., Hattori S., Kasai K.Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats . Diabetologia2005;48:1066-74.
31.
Leung PS, Carlsson POPancreatic islet renin angiotensin system: its novel roles in islet function and in diabetes mellitus. Pancreas2005;30:293-8.
32.
Engeli S., Schling P., Gorzelniak K. et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?Int J Biochem Cell Biol2003;35:807-25.
33.
Wang XL, Zhang L., Youker K. et al. Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes2006;55:2301-10.
34.
Bakker SJL , Jzerman RG, Teerlink T. et al. Cytosolic triacylglycerols and oxidative stress in central obesity: the missing link between excessive atherosclerosis, endothelial dysfunction, and β-cell failure. Atherosclerosis2000 ;148:17-21.
